Pepaxti

melphalan flufenamide hydrochloride · Oncopeptides AB (publ)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pepaxti, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: EMA Authorised: Pepaxti (Melphalan flufenamide hydrochloride) — Oncopeptides AB (publ)